Bleeding and thrombosis outcomes in hospitalised COVID-19 patients on low-molecular-weight heparin and antiplatelet therapy

Bleeding and thrombosis outcomes in hospitalised COVID-19 patients on low-molecular-weight heparin and antiplatelet therapy

Background. An increased incidence of thromboembolic events in hospitalised COVID‐19 patients has been demonstrated despite the use of low‐molecular‐weight heparin (LMWH). Antiplatelet therapy prior to admission and early in the disease course has been hypothesised to be protective against...

Full description

Bibliographic Details
Main Authors: V Pillay-Fuentes Lorente, R van Rensburg, M S Moolla, M McCaul, A Parker, J Taljaard, H Reuter, E H Decloedt
Format: Article
Language:English
Published: South African Medical Association 2022-07-01
Series:South African Medical Journal
Subjects:
COVID-19
thrombosis
Online Access:https://samajournals.co.za/index.php/samj/article/view/17

Similar Items

Similar Items